GPT and metabolic dysfunction-associated steatotic liver disease: ALT elevation can be contributed from both NAFLD and HBV infection; however, no specific recommendations for HBV treatment in the setting of concurrent NAFLD and hepatitis B. There are some controversial observations that NAFLD may influence the virological response of HBV antiviral therapy.